What is NDC 49281-590?

49281-590 is the product NDC for MenQuadfi, Neisseria meningitidis group a capsular polysaccharide tetanus toxoid conjugate antigen 10 ug/.5mL + 3 more ingredients injection, solution, listed with the FDA by Sanofi Vaccines US Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

MenQuadfi (NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN).

What is the active ingredient?

Neisseria meningitidis group a capsular polysaccharide tetanus toxoid conjugate antigen, Neisseria meningitidis group c capsular polysaccharide tetanus toxoid conjugate antigen, Neisseria meningitidis group y capsular polysaccharide tetanus toxoid conjugate antigen, Neisseria meningitidis group w-135 capsular polysaccharide tetanus toxoid conjugate antigen.

Sanofi Vaccines US Inc., NDC labeler code 49281. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for MenQuadfi?

1 other product NDC are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

MenQuadfi NDC 49281-590 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)49281-590Labeler and product segments. Claims need a package NDC.

Product NDC at billing width49281-0590Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
49281-590-01	4928105900149281059001	1 VIAL, SINGLE-DOSE in 1 CARTON (49281-590-01) / .5 mL in 1 VIAL, SINGLE-DOSE (49281-590-58)Marketed from Apr 23, 2020
49281-590-05	4928105900549281059005	5 VIAL, SINGLE-DOSE in 1 CARTON (49281-590-05) / .5 mL in 1 VIAL, SINGLE-DOSE (49281-590-58)Marketed from Apr 23, 2020
49281-590-10	4928105901049281059010	10 VIAL, SINGLE-DOSE in 1 CARTON (49281-590-10) / .5 mL in 1 VIAL, SINGLE-DOSE (49281-590-58)Marketed from Apr 23, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): MenQuadfi
Generic name (nonproprietary): neisseria meningitidis group a capsular polysaccharide tetanus toxoid conjugate antigen, neisseria meningitidis group c capsular polysaccharide tetanus toxoid conjugate antigen, neisseria meningitidis group y capsular polysaccharide tetanus toxoid conjugate antigen, and neisseria meningitidis group w-135 capsular polysaccharide tetanus toxoid conjugate antigen
Active ingredients: Neisseria meningitidis group a capsular polysaccharide tetanus toxoid conjugate antigen — 10 ug/.5mLNeisseria meningitidis group c capsular polysaccharide tetanus toxoid conjugate antigen — 10 ug/.5mLNeisseria meningitidis group y capsular polysaccharide tetanus toxoid conjugate antigen — 10 ug/.5mLNeisseria meningitidis group w-135 capsular polysaccharide tetanus toxoid conjugate antigen — 10 ug/.5mL
Dosage form: Injection, Solution
Route: Intramuscular
Labeler: Sanofi Vaccines US Inc.NDC labeler code 49281
Product type: Vaccine
Marketing category: BLA — Biologics License ApplicationApplication BLA 125701
Marketing start: Apr 23, 2020
Listing expires: Dec 31, 2027
Identifiers: Product ID 49281-590_faddb625-a9a9-4bcf-829e-033c11d2cc1fSPL ID faddb625-a9a9-4bcf-829e-033c11d2cc1f

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Immunization administration (CPT 90460–90474)

Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.

How CPT relates to drug billing

NDC on a medical claim

N449281059001 followed by a unit qualifier and the quantity

Package 49281-0590-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 49281-590

What is NDC 49281-590?: 49281-590 is the product NDC for MenQuadfi, Neisseria meningitidis group a capsular polysaccharide tetanus toxoid conjugate antigen 10 ug/.5mL + 3 more ingredients injection, solution, listed with the FDA by Sanofi Vaccines US Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: MenQuadfi (NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN).
What is the active ingredient?: Neisseria meningitidis group a capsular polysaccharide tetanus toxoid conjugate antigen, Neisseria meningitidis group c capsular polysaccharide tetanus toxoid conjugate antigen, Neisseria meningitidis group y capsular polysaccharide tetanus toxoid conjugate antigen, Neisseria meningitidis group w-135 capsular polysaccharide tetanus toxoid conjugate antigen.
Who is the labeler?: Sanofi Vaccines US Inc., NDC labeler code 49281. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for MenQuadfi?: 1 other product NDC are listed under this name. See all MenQuadfi NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other MenQuadfi NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Menquadfineisseria meningitidis group a capsular polysaccharide tetanus toxoid conjugate antigen, neisseria meningitidis group c capsular polysaccharide tetanus toxoid conjugate antigen, neisseria meningitidis group y capsular polysaccharide tetanus toxoid conjugate antigen, and neisseria meningitidis group w-135 capsular polysaccharide tetanus toxoid conjugate antigen	Neisseria meningitidis group a capsular polysaccharide tetanus toxoid conjugate antigen 10 ug/.5mL + 3 more ingredients	Injection, SolutionIntramuscular	A-S Medication Solutions	50090-6180	50090-6180-00

Other NDCs under BLA 125701

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BLA 125701
Product	Strength	Form · route	Labeler	Product NDC
Menquadfineisseria meningitidis group a capsular polysaccharide tetanus toxoid conjugate antigen, neisseria meningitidis group c capsular polysaccharide tetanus toxoid conjugate antigen, neisseria meningitidis group y capsular polysaccharide tetanus toxoid conjugate antigen, and neisseria meningitidis group w-135 capsular polysaccharide tetanus toxoid conjugate antigen	Neisseria meningitidis group a capsular polysaccharide tetanus toxoid conjugate antigen 10 ug/.5mL + 3 more ingredients	Injection, SolutionIntramuscular	A-S Medication Solutions	50090-6180